To tackle America’s gun problem, a growing number of states are using Medicaid dollars to pay for community-based programs intended to stop shootings.
Gilead must be held accountable for the harm caused by ‘patent hopping’ an HIV treatment
Gilead Sciences, a pharma company that dominates the market for HIV treatments, agreed in June to settle a case in federal court for $40 million